CBX4 is overexpressed in BC and functions as an oncogene by downregulating miR-137, which in turn enhances the activation of the Notch1 signaling pathway promoting epithelial-mesenchymal transition (EMT), invasion, and growth of BC cell lines [79]. Here, CBX4 is linked to breast cancer.